K M Mohler

3.1k citations

23 papers · 2.5k indexed · 2 hit papers · h-index 15

Immunology top 2%
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 4
- Immune Response and Inflammation 3
Immunology and Allergy top 2%
Virology top 5%
Rheumatology top 5%
Parasitology top 5%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 6
Cancer Research
- Protease and Inhibitor Mechanisms 4
Oncology
- Cytokine Signaling Pathways and Interactions 4
- CAR-T cell therapy research 3

Co-authors: Kathleen S. Picha Mark Kennedy M B Widmer Victor Fung Hassan Madani Roy A. Black David R. Anderson João S. Silva
Cited by: Immunology Immunology and Allergy Virology
Journals: The Journal of Immunology (7 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Canada

In The Last Decade

K M Mohler

21 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by K M Mohler

Since Specialization

Citations

This map shows the geographic impact of K M Mohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K M Mohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K M Mohler more than expected).

Fields of papers citing papers by K M Mohler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K M Mohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K M Mohler. The network helps show where K M Mohler may publish in the future.

Co-authorship network

The 25 scholars most cited alongside K M Mohler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K M Mohler Line = papers co-authored together K M Mohler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys Lara D. Veeken ·Cheryl Nickerson‐Nutter,Lioudmila Tchistiakova,Nilufer P. Seth,Marion T. Kasaian,智雄井上,Stéphane Olland,Richard Zollner,William Brady,K M Mohler,Peter Baum,Alan F. Wahl,Donna L. Herber,Yulia Vugmeyster,Susagna Argemí,Neil M. Wolfman,Davinder Gill,Mary Collins,Kyriaki Dunussi‐Joannopoulos	2011	6
2	Small Modular ImmunoPharmaceutical (SMIPTM) Molecules Directed at the TCR Complex Block Acute Graft Versus Host Disease and Cause Minimal Cytokine Release In Vivo (145.30) The Journal of Immunology ·Travis Beckett,Ceyhan Öztürk,Nu'man Yasir,Valerie Odegard,K M Mohler,Catherine J. McMahan	2010	0
3	Small Modular ImmunoPharmaceutical (SMIP™) Molecules Directed at the TCR Complex (CD3) Block T Cell Activation and Cause Minimal Cytokine Release In Vitro (96.25) The Journal of Immunology ·Ceyhan Öztürk,Travis Beckett,Valerie Odegard,Xiao Heng,K M Mohler,Catherine J. McMahan	2010	0
4	Efficacy of SMIP-016, a novel CD37-directed biologic therapy, in human NHL tumor xenograft models Journal of Clinical Oncology ·D. Barone,C. Nilsson,J A Ledbetter,Martha Hayden-Ledbetter,K M Mohler	2006	1
5	Identification and Characterization of 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3 S)thiomorpholinecarboxamide (TMI-1), a Novel Dual Tumor Necrosis Factor-α-Converting Enzyme/Matrix Metalloprotease Inhibitor for the Treatment of Rheumatoid Arthritis Journal of Pharmacology and Experimental Therapeutics ·Yuhua Zhang,Jun Xu,Jeremy I. Levin,Martin Hegen,Guangde Li,Heidi Robertshaw,Fionula M. Brennan,Terri Cummons,В. Ивасечко,Nichole R. Vansell,Cheryl Nickerson‐Nutter,D. Barone,K M Mohler,Roy A. Black,J.S. Skotnicki,Jay Gibbons,Marc Feldmann,Philip Frost,G R Larsen,Lih‐Ling Lin	2004	74
6	Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors Bioorganic & Medicinal Chemistry Letters ·Arie Zask,Ying Gu,J. Donald Albright,Xinling Du,Michael E. Hogan,Jeremy I. Levin,Steven E. Gilbert,Loran M. Killar,Anita Sung,John F. DiJoseph,Michele A. Sharr,Catherine Roth,Stacey Skala,Guofeng Jin,Rebecca Cowling,K M Mohler,D. Barone,Roy A. Black,Carl J. March,J.S. Skotnicki	2003	26
7	Immune Function in Patients with Rheumatoid Arthritis Treated with Etanercept Clinical Immunology ·Larry W. Moreland,R. Pat Bucy,Michael E. Weinblatt,K M Mohler,G Spencer-Green,W. Winn Chatham	2002	45
8	Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1′ group Bioorganic & Medicinal Chemistry Letters ·Jeremy I. Levin,Medicharala V. Jaganadham,G. E. Assousa,Frances C. Nelson,Loran M. Killar,Stacey Skala,Anita Sung,Guofeng Jin,Rebecca Cowling,D. Barone,Carl J. March,K M Mohler,Roy A. Black,J.S. Skotnicki	2002	62
9	Periosteal Hyperostosis (Exostosis) in DBA/1 Male Mice Toxicologic Pathology ·JoAnn C. L. Schuh,Bennett Ptak,Yin Yin Pei,Lucile Bagwell,K M Mohler,D. Barone	2002	2
10	The discovery of anthranilic acid-based mmp inhibitors. Part 3: incorporation of basic amines Bioorganic & Medicinal Chemistry Letters ·Jeremy I. Levin,Medicharala V. Jaganadham,G. E. Assousa,Frances C. Nelson,G H Thomson,John F. DiJoseph,Loran M. Killar,Stacey Skala,Anita Sung,Michele A. Sharr,Catherine Roth,Guofeng Jin,Rebecca Cowling,Li Di,I Gusti Lanang Made Rudiartha,C. Baum,Carl J. March,K M Mohler,Roy A. Black,Jerauld S. Skotnicki	2001	30
11	Poxvirus Genomes Encode a Secreted, Soluble Protein That Preferentially Inhibits β Chemokine Activity yet Lacks Sequence Homology to Known Chemokine Receptors Virology ·Craig A. Smith,Terri Smith,Pamela J. Smolak,Della Friend,Jiun-Lee Chang,Mary Gerhart,Linda Park,David J. Pickup,Arao B. Oliveira,K M Mohler,Ken Schooley,Raymond G. Goodwin	1997	158
12	A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. The Journal of Experimental Medicine ·Paul D. Crowe,Barbara Walter,K M Mohler,David R. Hoying,Roy A. Black,Carl F. Ware	1995	213
13	A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor The Journal of Immunology ·Jürgen Müllberg,Fiona H. Durie,David R. Hoying,Mark R. Alderson,Stefan Rose‐John,David Cosman,Roy A. Black,K M Mohler	1995	215
14	Failure to inhibit endotoxin-induced uveitis with soluble TNF receptors James T. Rosenbaum,江草安彦,Maayan Waldman,Muh. Syafaat S. Kuba,Arao B. Oliveira,David R. Hoying,Roberta Hanna,K M Mohler	1994	5
15	Pharmacokinetic Parameters and Biodistribution of Soluble Cytokine Receptors PubMed ·Cindy Jacobs,M P Beckmann,K M Mohler,Charles R. Maliszewski,William C. Fanslow,David H. Lynch	1993	32
16	Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.breakdown → The Journal of Immunology ·K M Mohler,Arao B. Oliveira,RK Paterson,Carolina Villalobos Méndez,正義金,Victor Fung,Hassan Madani,M B Widmer	1993	686
17	Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. The Journal of Experimental Medicine ·João S. Silva,Philip Morrissey,K H Grabstein,K M Mohler,David R. Anderson,Steven G. Reed	1992	314
18	Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recoverybreakdown → The Journal of Immunology ·Mark Kennedy,Arao B. Oliveira,Kathleen S. Picha,K M Mohler	1992	543
19	Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization. The Journal of Immunology ·K M Mohler,L D Butler	1990	52
20	Mechanisms of neonatal transplantation tolerance. PubMed ·J. Wayne Streilein,K M Mohler,Peter J. Wood	1987	14

About K M Mohler

K M Mohler is a scholar working on Immunology, Cancer Research and Oncology, having authored 23 papers that have together received 2.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers), Protease and Inhibitor Mechanisms (4 papers), T-cell and B-cell Immunology (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Immunology (1.2k citations), Immunology and Allergy (227 citations) and Virology (114 citations). K M Mohler has collaborated with scholars based in United States and Canada. Frequent co-authors include Kathleen S. Picha, Mark Kennedy, M B Widmer, Victor Fung, Hassan Madani, Roy A. Black, David R. Anderson, João S. Silva, Steven G. Reed and K H Grabstein. Their work appears in journals such as The Journal of Immunology, Bioorganic & Medicinal Chemistry Letters, Journal of Clinical Oncology, The Journal of Experimental Medicine and Stem Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact